CV Sciences (CVSI) Gross Margin (2013 - 2026)

CV Sciences' (CVSI) quarterly Gross Margin came in at 48.89% in Q1 2026, up 291.0% year-on-year from 12.5% in Q1 2025, and down 3.25% quarter-over-quarter from 50.53% in Q4 2025.

CV Sciences (CVSI) Gross Margin (2013 - 2026) Analysis & Trends

CV Sciences has disclosed Gross Margin across 14 years of filings, most recently posting 48.89% for Q1 2026.

  • Gross Margin for Q1 2026 came in at 48.89%, up 291.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 49.75% (up 420.0% YoY), and the FY2025 annual result was 48.97%, up 333.0% from the prior year.
  • Gross Margin came in at 48.89% for Q1 2026 at CV Sciences, down from 50.53% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 50.94% in Q2 2025 to a low of 26.0% in Q1 2022.
  • The 5-year median for Gross Margin is 45.83% (2023), against an average of 43.72%.
  • Across the five-year window, Gross Margin plunged 2268 bps in 2022 and soared 1697 bps in 2023, its largest moves.
  • CV Sciences' Gross Margin stood at 40.37% in 2022, then increased by 14 bps to 45.83% in 2023, then retreated by 6 bps to 43.18% in 2024, then rose by 17 bps to 50.53% in 2025, then declined by 3 bps to 48.89% in 2026.
  • The last three Gross Margin figures came in at 48.89% (Q1 2026), 50.53% (Q4 2025), and 48.5% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 49.52%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 71.66%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 82.93%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 49.50%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 98.31%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.26%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -293.83%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 65.25%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 61.20%
10 CV Sciences - - 1.56 Mn 48.89%

Historic Data

Download Data
DateValue
Mar 31, 2026 48.89%
Dec 31, 2025 50.53%
Sep 30, 2025 48.50%
Jun 30, 2025 50.94%
Mar 31, 2025 45.98%
Dec 31, 2024 43.18%
Sep 30, 2024 46.00%
Jun 30, 2024 47.04%
Mar 31, 2024 46.30%
Dec 31, 2023 45.83%
Sep 30, 2023 45.07%
Jun 30, 2023 43.32%
Mar 31, 2023 42.96%
Dec 31, 2022 40.37%
Sep 30, 2022 41.64%
Jun 30, 2022 30.69%
Mar 31, 2022 26.00%
Dec 31, 2021 32.40%
Sep 30, 2021 46.17%
Jun 30, 2021 44.66%